PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities - Archive ouverte HAL Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2021

PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities

Hélène Neyret-Kahn
Florent Dufour
Elodie Chapeaublanc
François Radvanyi

Résumé

PPARactivation is a critical event in luminal muscle-invasive bladder cancer (MIBC) tumorigenesis, favoring both tumor cell growth and microenvironment modulation toward tumor immune escape. Conversely, the down-regulation of PPARactivity in basal MIBC suggests tumor suppressive effects in this subgroup. Here, we report genetic, epigenetic and functional evidence to support the tumor suppressor role for PPAR in basal bladder tumors. We identified hemizygous deletions, DNA hyper-methylation and loss-of-function mutations of PPARin basal MIBC, associated with PPAR under-expression and its decreased activity. Re-expression of PPARin basal tumor cells resulted in the activation of PPAR-dependent transcription program that modulated fatty acid metabolism and cell differentiation and decreased cell growth, which could partly rely on EGFR down-regulation. Structure-function studies of two PPAR mutant revealed a destabilization of a region important for coactivator recruitment and should help develop potent molecules to activate PPAR as a therapeutic strategy for basal MIBC. The identification of this subtype-dependent dual role of PPAR in MIBC strengthens the critical role of PPAR in bladder tumorigenesis and reinforces the interest in stratified medicine based on tumor molecular subtyping.
Fichier principal
Vignette du fichier
Biorxivversion.pdf (6.03 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03424976 , version 1 (16-11-2021)

Identifiants

Citer

Laure Coutos-Thévenot, Syrine Beji, Hélène Neyret-Kahn, Quentin Pippo, Jacqueline Fontugne, et al.. PPARγ is a tumor suppressor in basal bladder tumors offering new potential therapeutic opportunities. 2021. ⟨hal-03424976⟩
64 Consultations
58 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More